FIELD: medicine, pharmaceutics.
SUBSTANCE: invention refers to medicine, experimental and clinical pharmacology. The substance of the method: oxidised dextran is dissolved in a tris-acetate buffer solution with pH 5.0-5.5; the prepared solution is added with biotin hydrazide in a relation to oxidised dextran equal to 1:(20-25); the prepared solution is heated to 80-90°C and settled for 30-60 minutes.
EFFECT: preparing the high-quality biotinylated derivative of oxidised dextran providing higher sensitivity of its immune immunoassay in blood serum.
3 cl, 2 dwg, 4 tbl, 4 ex
Title | Year | Author | Number |
---|---|---|---|
METHOD OF PRODUCING OXIDISED DEXTRAN, SUITABLE FOR ITS VISUALIZATION IN BLOOD SERUM | 2019 |
|
RU2690380C1 |
METHOD FOR CELLULAR LABORATORY IMMUNITY OF LABORATORY ANIMALS | 2018 |
|
RU2709809C1 |
METHOD FOR PREVENTION OF GASTROINTESTINAL DISEASES OF YOUNG CATTLE | 2019 |
|
RU2722161C1 |
METHOD FOR INCREASING NATURAL RESISTANCE OF YOUNG CATTLE | 2022 |
|
RU2794852C1 |
METHOD FOR THE PREVENTION OF MASTITIS IN CATTLE | 2022 |
|
RU2794621C1 |
METHOD FOR TREATMENT OF MASTITIS IN CATTLE | 2022 |
|
RU2787754C1 |
METHOD FOR PREVENTION OF EIMERIOSIS IN CHICKENS | 2020 |
|
RU2750707C1 |
METHOD OF OBTAINING FLUORESCENT DERIVATIVES OF DEXRANS | 2010 |
|
RU2426545C1 |
METHOD FOR TRAY SENSITISATION FOR POLYSACCHARIDE ANTIGEN ENZYME IMMUNOASSAY | 2008 |
|
RU2380709C1 |
METHOD FOR IMMUNOFLUORESCENT DETECTION OF PROTECTIVE ANTIGEN OF ANTHRAX AGENT | 2011 |
|
RU2478970C1 |
Authors
Dates
2014-12-27—Published
2013-10-17—Filed